Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
Figure out How to Clean and Really focus on Your Lab Jewel - 2The Green Transformation: 5 Feasible Living Practices
- 3The Main 15 Applications for Efficiency and Association
- 4Bennu asteroid samples provide clues about solar system origins and 'space gum'
- 5IndiGo lands IATA chief Willie Walsh as new CEO
- US FDA panel to weigh bid to market nicotine pouches as lower-risk than cigarettes
- Who plays Moana in the live-action remake? What to know about Catherine Lagaʻaia.
- Three killed as unfinished building collapses on church service in Ghana
- Two Indonesian UN peacekeepers killed in explosion in Lebanon
- Vote In favor of Feasible Way You Prescribe to Shop for Garments
- Hamas propaganda expert explains Israel's internal conflicts influenced Hamas's Oct. 7 assault
- EU foreign ministers commemorate Russian massacre in Bucha
- Tickets for 'Stranger Things' Season 5 finale, to be shown in movie theaters on New Year's Eve, go on sale today. Here's how you can save your seat.
- ‘Aid for Ukraine’ pierogi fundraiser event
